Canopy Growth (TSX:WEED) CEO Ousted: Is the Stock Still a Buy?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is reeling from the unexpected termination of Bruce Linton. The stock lost so much power, which is a telling sign that investors should hold off on buying WEED.

| More on:
question marks written reminders tickets

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The departure of the embattled Bruce Linton from Canopy Growth (TSX:WEED)(NYSE:CGC) on July 3 seems to be hurting the largest cannabis company in the world. The company’s founder was mainly responsible for Canopy’s growth for the past six years. Today, there’s doubt as to whether investors should still buy WEED.

Linton left the company with 5.6 million square feet of cultivation capacity in 10 sites. He also obtained the licence from Health Canada for the more than 4.8 million square feet.

Overall, Linton did a superb job of priming Canopy Growth for massive production. But his dreams of making the company the industry stalwart were shattered. The Constellation Brands-dominated board decided to kick Linton out.

Stock performance

The day after Linton stepped down, WEED dropped by 0.84% to $53.07. As of July 12, the price has gone down by 16% to $44.58. The same thing happened on the NYSE, as the stock pointed downward.

There are mixed reactions on the firing of the rock star in the cannabis space. Some are saying it’s good for the company with kind words for Linton. The former CEO didn’t do significant damage except that the biggest investor became too impatient.

Others think Linton’s plans were great but the spending was excessive, and so is the bleeding on the bottom line. The Corona-beer maker was extremely worried about the escalating losses that were impacting heavily on its operating results.

Thus, Constellation Brands had to no choice but to appoint co-CEO Mark Zekulin as the interim chief executive. A new CEO will come by December.

New direction

According to management, the replacement should have international experience and ideally a strong background in pharmaceuticals. The person would be tasked to improve market share and penetrate new markets or create new business segments.

But the pressure is on. Canopy Growth’s net losses have ballooned by 1,204% in 2018. The next-CEO should be able to turn the company around. In the meantime, expenses need to be curtailed including cutting down on marketing expenses.

The focus moving forward will be on profitability. Canopy Growth is expected to turn in profits by 2021 but not any time sooner. Maybe the company really needs a fresh start.

As for Bruce Linton, we won’t see him move to another cannabis producer. He had a non-compete clause in his employment arrangement with Canopy Growth. Linton would’ve be an asset and leader in industry rivals in need of a visionary.

Hold the purchase

Canopy Growth just dropped the industry leader tag with the abrupt exit of Bruce Linton. The race is wide open, and a company not named Canopy Growth might assume the leadership role.

I’m sure the company will survive this setback and perhaps come out stronger. But until it’s headless, it is highly doubtful if the price level can be maintained. The time to invest in Canopy Growth will come. But it’s not today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »